Better Buy: Vertex vs. CRISPR

It’s very common in the life sciences industry for small biotech companies to partner with larger pharmaceutical businesses. The biotech company typically has innovative treatments in the pipeline with years of clinical trials ahead of them, while the pharma…

Click here to view the original article.